Global Non-small Cell Lung Cancer Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4919368
- 85 Pages
- March 2022
- Pharmaceuticals
The United States Non-small Cell Lung Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-small Cell Lung Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Non-small Cell Lung Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-small Cell Lung Cancer Drugs players cover AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and F. Hoffmann-La Roche Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-small Cell Lung Cancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Biologics
Small Molecule Targeted Therapy
Chemotherapy
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lung Adenocarcinoma
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-small Cell Lung Cancer Drugs Market Size 2017-2028
2.1.2 Non-small Cell Lung Cancer Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-small Cell Lung Cancer Drugs Segment by Type
2.2.1 Biologics
2.2.2 Small Molecule Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Other
2.3 Non-small Cell Lung Cancer Drugs Market Size by Type
2.3.1 Non-small Cell Lung Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
2.4 Non-small Cell Lung Cancer Drugs Segment by Application
2.4.1 Lung Adenocarcinoma
2.4.2 Squamous Cell Lung Carcinoma
2.4.3 Large-cell Lung Carcinoma
2.5 Non-small Cell Lung Cancer Drugs Market Size by Application
2.5.1 Non-small Cell Lung Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
3 Non-small Cell Lung Cancer Drugs Market Size by Player
3.1 Non-small Cell Lung Cancer Drugs Market Size Market Share by Players
3.1.1 Global Non-small Cell Lung Cancer Drugs Revenue by Players (2020-2022)
3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Non-small Cell Lung Cancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-small Cell Lung Cancer Drugs by Regions
4.1 Non-small Cell Lung Cancer Drugs Market Size by Regions (2017-2022)
4.2 Americas Non-small Cell Lung Cancer Drugs Market Size Growth (2017-2022)
4.3 APAC Non-small Cell Lung Cancer Drugs Market Size Growth (2017-2022)
4.4 Europe Non-small Cell Lung Cancer Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022)
5.2 Americas Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
5.3 Americas Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022)
6.2 APAC Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
6.3 APAC Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-small Cell Lung Cancer Drugs by Country (2017-2022)
7.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
7.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-small Cell Lung Cancer Drugs by Region (2017-2022)
8.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-small Cell Lung Cancer Drugs Market Forecast
10.1 Global Non-small Cell Lung Cancer Drugs Forecast by Regions (2023-2028)
10.1.1 Global Non-small Cell Lung Cancer Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Non-small Cell Lung Cancer Drugs Forecast
10.1.3 APAC Non-small Cell Lung Cancer Drugs Forecast
10.1.4 Europe Non-small Cell Lung Cancer Drugs Forecast
10.1.5 Middle East & Africa Non-small Cell Lung Cancer Drugs Forecast
10.2 Americas Non-small Cell Lung Cancer Drugs Forecast by Country (2023-2028)
10.2.1 United States Non-small Cell Lung Cancer Drugs Market Forecast
10.2.2 Canada Non-small Cell Lung Cancer Drugs Market Forecast
10.2.3 Mexico Non-small Cell Lung Cancer Drugs Market Forecast
10.2.4 Brazil Non-small Cell Lung Cancer Drugs Market Forecast
10.3 APAC Non-small Cell Lung Cancer Drugs Forecast by Region (2023-2028)
10.3.1 China Non-small Cell Lung Cancer Drugs Market Forecast
10.3.2 Japan Non-small Cell Lung Cancer Drugs Market Forecast
10.3.3 Korea Non-small Cell Lung Cancer Drugs Market Forecast
10.3.4 Southeast Asia Non-small Cell Lung Cancer Drugs Market Forecast
10.3.5 India Non-small Cell Lung Cancer Drugs Market Forecast
10.3.6 Australia Non-small Cell Lung Cancer Drugs Market Forecast
10.4 Europe Non-small Cell Lung Cancer Drugs Forecast by Country (2023-2028)
10.4.1 Germany Non-small Cell Lung Cancer Drugs Market Forecast
10.4.2 France Non-small Cell Lung Cancer Drugs Market Forecast
10.4.3 UK Non-small Cell Lung Cancer Drugs Market Forecast
10.4.4 Italy Non-small Cell Lung Cancer Drugs Market Forecast
10.4.5 Russia Non-small Cell Lung Cancer Drugs Market Forecast
10.5 Middle East & Africa Non-small Cell Lung Cancer Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Non-small Cell Lung Cancer Drugs Market Forecast
10.5.2 South Africa Non-small Cell Lung Cancer Drugs Market Forecast
10.5.3 Israel Non-small Cell Lung Cancer Drugs Market Forecast
10.5.4 Turkey Non-small Cell Lung Cancer Drugs Market Forecast
10.5.5 GCC Countries Non-small Cell Lung Cancer Drugs Market Forecast
10.6 Global Non-small Cell Lung Cancer Drugs Forecast by Type (2023-2028)
10.7 Global Non-small Cell Lung Cancer Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Non-small Cell Lung Cancer Drugs Product Offered
11.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Information
11.2.2 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product Offered
11.2.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bristol-Myers Squibb Company Main Business Overview
11.2.5 Bristol-Myers Squibb Company Latest Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Information
11.3.2 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product Offered
11.3.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Eli Lilly and Company Main Business Overview
11.3.5 Eli Lilly and Company Latest Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Information
11.4.2 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product Offered
11.4.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.4.5 F. Hoffmann-La Roche Ltd Latest Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Information
11.5.2 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product Offered
11.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck & Co., Inc. Main Business Overview
11.5.5 Merck & Co., Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Non-small Cell Lung Cancer Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Biologics
Table 3. Major Players of Small Molecule Targeted Therapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Other
Table 6. Non-small Cell Lung Cancer Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 9. Non-small Cell Lung Cancer Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Non-small Cell Lung Cancer Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Player (2020-2022)
Table 14. Non-small Cell Lung Cancer Drugs Key Players Head office and Products Offered
Table 15. Non-small Cell Lung Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-small Cell Lung Cancer Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Non-small Cell Lung Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Non-small Cell Lung Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Non-small Cell Lung Cancer Drugs
Table 45. Key Market Challenges & Risks of Non-small Cell Lung Cancer Drugs
Table 46. Key Industry Trends of Non-small Cell Lung Cancer Drugs
Table 47. Global Non-small Cell Lung Cancer Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Non-small Cell Lung Cancer Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Non-small Cell Lung Cancer Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Non-small Cell Lung Cancer Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Non-small Cell Lung Cancer Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Non-small Cell Lung Cancer Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. AstraZeneca Details, Company Type, Non-small Cell Lung Cancer Drugs Area Served and Its Competitors
Table 54. AstraZeneca Non-small Cell Lung Cancer Drugs Product Offered
Table 55. AstraZeneca Non-small Cell Lung Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Bristol-Myers Squibb Company Details, Company Type, Non-small Cell Lung Cancer Drugs Area Served and Its Competitors
Table 59. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product Offered
Table 60. Bristol-Myers Squibb Company Main Business
Table 61. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Bristol-Myers Squibb Company Latest Developments
Table 63. Eli Lilly and Company Details, Company Type, Non-small Cell Lung Cancer Drugs Area Served and Its Competitors
Table 64. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product Offered
Table 65. Eli Lilly and Company Main Business
Table 66. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Eli Lilly and Company Latest Developments
Table 68. F. Hoffmann-La Roche Ltd Details, Company Type, Non-small Cell Lung Cancer Drugs Area Served and Its Competitors
Table 69. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product Offered
Table 70. F. Hoffmann-La Roche Ltd Main Business
Table 71. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. F. Hoffmann-La Roche Ltd Latest Developments
Table 73. Merck & Co., Inc. Details, Company Type, Non-small Cell Lung Cancer Drugs Area Served and Its Competitors
Table 74. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product Offered
Table 75. Merck & Co., Inc. Main Business
Table 76. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Merck & Co., Inc. Latest Developments
List of Figures
Figure 1. Non-small Cell Lung Cancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Type in 2021
Figure 7. Non-small Cell Lung Cancer Drugs in Lung Adenocarcinoma
Figure 8. Global Non-small Cell Lung Cancer Drugs Market: Lung Adenocarcinoma (2017-2022) & ($ Millions)
Figure 9. Non-small Cell Lung Cancer Drugs in Squamous Cell Lung Carcinoma
Figure 10. Global Non-small Cell Lung Cancer Drugs Market: Squamous Cell Lung Carcinoma (2017-2022) & ($ Millions)
Figure 11. Non-small Cell Lung Cancer Drugs in Large-cell Lung Carcinoma
Figure 12. Global Non-small Cell Lung Cancer Drugs Market: Large-cell Lung Carcinoma (2017-2022) & ($ Millions)
Figure 13. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Application in 2021
Figure 14. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Player in 2021
Figure 15. Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Non-small Cell Lung Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Non-small Cell Lung Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Non-small Cell Lung Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Non-small Cell Lung Cancer Drugs Value Market Share by Country in 2021
Figure 21. Americas Non-small Cell Lung Cancer Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Non-small Cell Lung Cancer Drugs Market Size Market Share by Application in 2021
Figure 23. United States Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Non-small Cell Lung Cancer Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Non-small Cell Lung Cancer Drugs Market Size Market Share by Application in 2021
Figure 29. China Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Non-small Cell Lung Cancer Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Non-small Cell Lung Cancer Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
